Skip to main content

Advertisement

SpringerLink
Log in

Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis

  • Short Communication
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Chemotherapy-induced peripheral neuropathy (CIPN) is an issue for both cancer patients and specialists, and the number of cases of CIPN is growing with the increasing number of cancer patients worldwide. CIPN is often caused by common anticancer drugs such as taxanes and platinum analogs. These are key drugs for various cancers including colorectal and gastric cancers. However, there are currently no effective drugs to prevent CIPN. Goshajinkigan, a Japanese traditional herbal medicine (Kampo), is a promising drug which is used to treat diabetic neuropathy in Japan. This systematic review will assess the efficacy and safety of Goshajinkigan for reducing CIPN in cancer patients receiving chemotherapy.

Methods and analysis

We will conduct a comprehensive search of relevant randomized controlled trials in Scopus, Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and ICHUSHI. Two review authors will independently assess studies for inclusion and consult a third review author if necessary. The risk of bias of the included studies will be assessed according to the Cochrane risk of bias tool. We will investigate heterogeneity using forest plots and the chi-square test. When there are enough studies and any heterogeneity, we will use a random-effects model. Otherwise, we will use a fixed-effects model.

Ethics and dissemination

This is a protocol for systematic review and meta-analysis and does not need ethics approval. We will disseminate the findings of this review through publication in a peer-reviewed journal.

Trial registration number

PROSPERO CRD42016045224

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. World Health Organization, Cancer. http://www.who.int/cancer/en/. Accessed 1 Oct 2016

  2. Postma TJ, Heimans JJ (2000) Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 11:509–513

    Article  CAS  PubMed  Google Scholar 

  3. Chu SH, Lee YJ, Lee ES et al (2015) Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Support Care Cancer 23:513–524

    Article  PubMed  Google Scholar 

  4. Ewertz M, Qvortrup C, Eckhoff L (2015) Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol 54:587–591

    Article  CAS  PubMed  Google Scholar 

  5. Hershman DL, Till C, Wright JD et al (2016) Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in Southwest Oncology Group clinical trials. J Clin Oncol 34:3014–3022

    Article  CAS  PubMed  Google Scholar 

  6. Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 22:2261–2269

    Article  PubMed  Google Scholar 

  7. Kono T, Mishima H, Shimada M et al (2009) Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE study). Jpn J Clin Oncol 39:847–849

    Article  PubMed  Google Scholar 

  8. Tawata M, Kurihara A, Nitta K et al (1994) The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy. Diabetes Res Clin Pract 26:121–128

    Article  CAS  PubMed  Google Scholar 

  9. Nishizawa M, Sutherland WH, Nukada H (1995) Gosha-jinki-gan (herbal medicine) in streptozocin-induced diabetic neuropathy. J Neurol Sci 132:177–181

    Article  CAS  PubMed  Google Scholar 

  10. Kono T, Mamiya N, Chisato N et al (2011) Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med 2011:418481

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ushio S, Egashira N, Sada H et al (2012) Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur J Cancer 48:1407–1413

    Article  CAS  PubMed  Google Scholar 

  12. Higgins JPT, Green S (editors) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from http://handbook.cochrane.org.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan

    Nobuaki Hoshino, Koya Hida, Riki Ganeko & Yoshiharu Sakai

Authors
  1. Nobuaki Hoshino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koya Hida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riki Ganeko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshiharu Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobuaki Hoshino.

Ethics declarations

Conflict of interest

Yoshiharu Sakai has received a research grant from Tsumura. The other authors declare that they have no conflict of interest.

Statement of human right

For this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoshino, N., Hida, K., Ganeko, R. et al. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis. Int J Colorectal Dis 32, 737–740 (2017). https://doi.org/10.1007/s00384-016-2727-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-016-2727-y

Keywords

Search

Navigation